“Artificial intelligence most likely saved Louie Quiros’s life.

Mr. Quiros, a 45-year-old caregiver and security guard, showed up at a Queens emergency room in February 2025. For the past four days, he said, he had been coughing up blood and finding it harder and harder to breathe.

His heart was beating fast, and he wasn’t getting much air to his lungs, but a chest X-ray showed no abnormalities. He also had an electrocardiogram, or ECG, a common test that records the heart’s electrical activity. It was abnormal but showed nothing that would lead to a clear diagnosis. It indicated he might have coronary heart disease — rare in someone his age. But, as it turned out, that was not his problem.

The emergency room doctors learned Mr. Quiros had been exposed to wildfire smoke on a recent visit to California and sent him home with asthma medicine and an inhaler.

Luckily for Mr. Quiros, that emergency room is part of NewYork-Presbyterian’s medical system. Researchers were analyzing all electrocardiograms done on patients in that medical system with an A.I. program, EchoNext, to see if it could find patterns in the scans indicating damage to the heart — patterns a human would not detect.

It’s part of a clinical trial evaluating the A.I. program, which was developed there by Dr. Pierre Elias, medical director of A.I. and cardiologist at NewYork-Presbyterian and Columbia University Irving Medical Center, and his colleagues. Dr. Elias says EchoNext reads an ECG less than 10 minutes after it is performed, and that they analyze nearly 500,000 ECGs a year. Dr. Elias has started a company, Pathway Labs, to market it.”

From New York Times.